Zole-F Ointment is a topical formulation combining Fluocinolone acetonide (0.01% w/w), a potent corticosteroid, with Miconazole (2% w/w), a broad-spectrum antifungal agent. This dual-action ointment is indicated for the treatment of inflammatory dermatoses complicated by fungal infections, such as tinea corporis, tinea cruris, and candidiasis with associated inflammation and pruritus. Fluocinolone acetonide exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting the release of inflammatory mediators, thereby reducing erythema, swelling, and itching. Miconazole acts by disrupting fungal cell membrane synthesis through inhibition of ergosterol biosynthesis, effectively eradicating dermatophytes and yeasts. Zole-F Ointment should be applied topically in a thin layer to the affected area twice daily or as directed by a healthcare professional. Treatment duration typically ranges from 2 to 4 weeks, depending on clinical response. Caution is advised in prolonged use or application over large areas to minimize potential corticosteroid-related adverse effects such as skin atrophy or systemic absorption. It is contraindicated in viral skin infections and hypersensitivity to any component. Patients should avoid contact with eyes and mucous membranes. Zole-F Ointment offers an effective therapeutic option for managing inflammatory fungal skin conditions requiring combined anti-inflammatory and antifungal treatment.